News search
Research 8 Jan 2019 The expression on lymphocytes of the molecule CD69 inversely predicts the development of subclinical (symptom-free) atherosclerosis independently of classical cardiovascular risk factors |
Research 19 Nov 2018 The scientific event, which took place in Madrid, brought together more than 100 researchers from different fields of cardiovascular biology |
Research 16 Nov 2018 The study results, published in the journal Nature Communications, identify several proteins implicated in this disease |
Research 19 Oct 2018 CNIC researchers have discovered a new inflammatory control mechanism that paves the way to controlling injury generated during the immune response |
Research 18 Oct 2018 Professor Eldad Tzahor, Director of the Cellular and Molecular Biology Laboratory at the Weizmann Institute of Science, in Rehovo (Israel). |
Research 10 Oct 2018 CNIC researchers have discovered that the immune system is important not only in the defense against disease but also for the day-to-day function of a healthy organism |
About the CNIC 27 Jul 2018 Dr. Göttgens gave the conference "Cellular States, Differentiation Trajectories and Regulatory Networks of Blood Cell Development" at the CNIC Seminar cycle, invited by Dr. Miguel Manzanares. |
About the CNIC 4 Jul 2018 ‘Clonal hematopoiesis and atherosclerosis’ will receive a total funding of $6,000,000, of which $712,500 correspond to the CNIC |
Research 3 Apr 2018 The study is published in Science Translational Medicine and was conducted by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) |
Research 3 Apr 2018 ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián |
- ‹ previous
- 18 of 26
- next ›